Investors

BSF Enterprise

Meeting Notices

GM Notice - September 2023

Annual Reports and Interim Results

Interim Results - 2024
Annual Report - 2023
Interim Financial Statements - 2023

Investor Presentation

Investor Presentation - October 2024

Rule 9 Waiver and General Meeting

Prospectus - 2023
Form of Proxy - 2023

RNS announcements

Click on an individual RNS announcement below for further information.

DateTitleClick for more details
21/01/2025BSF Enterprise and Sartorius Sign Strategic Collaboration to Drive Cost – Effective and Sustainable Biotech SolutionsView
27/12/2024Admission of Placing SharesView
18/12/20243DBT-Ltd Secures Prestigious Northern Accelerator Growth Support GrantView
04/12/2024Oversubscribed Fundraising of £500,000 to Support Strategic Objectives and Achieve Key MilestonesView
26/09/2024Portfolio UpdateView
12/08/2024Kerato partnership with University of MontrealView
18/06/2024PDMR NotificationView
16/06/2024Director/PDMR ShareholdingView
15/06/2024Notification of Transactions of DirectorsView
14/06/2024Director/PDMR ShareholdingView
14/06/2024Notification of Transactions of DirectorsView
13/06/2024Grant of OptionsView
11/06/2024Interim ResultsView
11/04/2024Successful Cultivated Leather PoC AgreementsView
20/03/2024Result of Annual General MeetingView
20/03/2024University CollaborationsView
14/03/2024BSF Investor EveningView
07/03/2024BSF Enterprise (Hong Kong) Ltd and Ivy Farm Technologies Enter PartnershipView
29/02/2024MoU with Sustainable Fashion Company Amelie PichardView
23/02/2024BSF AGM ProxyView
23/02/2024Notice of Annual General MeetingView
31/01/2024Full Year ResultsView
08/12/2023FOODTECH Joint Venture with CellRevView
26/10/2023New Cornea Company & Investor UpdateView
09/10/2023Participation in The ThinkEquity ConferenceView
26/09/2023Results of General Meeting Allotment of sharesView
18/09/20233D Bio-Tissues receives €612,000 grantView
11/09/2023Strategic UpdateView
07/09/2023Publication of Prospectus & Notice of GMView
17/07/2023City-Mix™ Bio-Pharmaceutical UpdateView
03/07/2023Opens Office in Hong KongView
30/06/2023Interim ResultsView
23/06/2023Cultivated Meat Approved for Consumption in USView
08/06/2023Appointment of US Investor Relations AgencyView
02/06/2023Successful Cultivated meat test conducted by BSFView
01/06/2023Publication of New ResearchView
30/05/2023Successful Cultivated Meat TestView
25/05/2023Admittance to trading on the OTCQB Venture MarketView
23/05/2023Leather shoes ‘grown in the lab’ by Newcastle biotech business just five years away, founder saysView
22/05/2023City-Mix™ Commercial Progress UpdateView
15/05/2023Lab-Grown Leather Update and Innovation Award WinView
14/04/2023Admission of Placing Shares & Subscription SharesView
12/04/2023Update to oversubscribed £2.9 million fundraiseView
29/03/2023Oversubscribed £2.9 million fundraiseView
15/03/2023Result of AGM General MeetingView
15/03/2023AGM StatementView
09/03/2023Application for Trading on US OTCQB Venture MarketView
20/02/2023AGM NoticeView
10/02/2023Allotment of sharesView
03/02/2023Newcastle scientists create UK’s first lab-made steakView
02/02/2023Newcastle scientists 3D Bio-Tissues produce and taste world’s first 100% cultivated meat steakView
01/02/2023Second Price Monitoring ExtnView
01/02/2023Price Monitoring ExtensionView
01/02/2023BSF Enterprise makes UK’s first cultivated pork steak, and eats itView
01/02/2023Raising the steaks: British scientists grow a pork steak in a LABORATORY that looks and smells just like real meatView
01/02/2023Second Price Monitoring ExtnView
01/02/2023Price Monitoring ExtensionView
01/02/2023Scientists produce world’s first cultivated steakView
01/02/2023UK Scientists produce 100% cultivated meatView
01/02/2023UK scientists produce “world’s first 100% cultivated meat steak”View
01/02/20233DBT Says it Has Developed the First Truly 100% Cultivated Meat Steak. Here’s Why.View
01/02/2023BSF Enterprise jumps after unveiling first full-scale fillet of lab-grown meatView
01/02/2023UK’s First Fillet of Cultivated Meat ProducedView
31/01/2023Annual Report and Financial Statement for the year ending 30 September 2022View
19/12/20223D Bio-Tissues enters partnership with New HarvestView
23/11/2022Second Price Monitoring ExtnView
23/11/2022Price Monitoring ExtensionView
23/11/20223D Bio-Tissues partners with cell growth companyView
15/11/2022Successful Prototypes of Lab-Grown Fillets of MeatView
15/11/2022BSF jumps after unveiling first fillets of lab-grown meat.View
15/11/2022BSF Enterprise soars on lab-grown meat.View
27/10/20223D Bio-Tissues receives €100,000 grantView
21/09/20223D Bio-Tissues Appoints Business DirectorView
18/07/2022Operational UpdateView
18/07/2022IN BRIEF: BSF Enterprise says on track to produce 100% lab-grown meatView
12/07/2022AGM NoticeView
29/06/2022Interim Financial StatementsView
17/06/2022AGM NoticeView
06/06/2022Appointment of new CFO and opening new London OfficeView
18/05/2022Newcastle-based tech pioneers 3DBT taken over in £1.25m move.View
17/05/2022Admission to Trading and First Day of DealingsView
17/05/2022BSF Enterprise completes artificial meat purchase.View
16/05/2022Results of General MeetingView
27/04/2022Conditional Placing to raise £1.75 millionView
27/04/2022BSF Enterprise raises cash to help with 3D Bio-Tissues deal.View
14/02/2022Annual Financial ReportView
27/12/2021BSF Enterprise to acquire 3D Bio-Tissues.View
24/12/2021AcquisitionView
16/08/2021Proposed Transaction and Suspension of ListingView
16/08/2021Suspension – BSF Enterprise PlcView
09/08/2021Appointment of DirectorView
04/05/2021Half-year ReportView
23/04/2021Half-year ReportView
06/04/2021Correction StatementView
01/04/2021Result of AGMView
01/04/2021Annual Financial ReportView
01/04/2021Notice of AGMView
04/03/2021AGM StatementView
04/08/2020Result of General MeetingView
16/07/2020AcquisitionView
31/03/2020Result of AGMView
26/03/2020Notice of AGMView
03/03/2020Notice of Annual General Meeting 2020View
03/02/2020Annual Financial ReportView
26/07/2019First Day of DealingsView

Corporate Governance

The Directors acknowledge the importance of high standards of corporate governance and intend, given the Company’s size and the constitution of the Board, to comply with the principles set out in the QCA Code. The QCA Code sets out a standard of minimum best practice for small and mid-size quoted companies.

Upon Admission, the Board will comprise four Directors, one of whom one will be an Executive Director and the remaining three Non-Executive Directors, reflecting a blend of different experiences and backgrounds.

The QCA Code states that a company should have at least two independent non-executive directors. At Admission the Company will only have one independent non-executive directors being Mr Dennis Ow. The Board believes that the composition of the Board brings a desirable range of skills and experience in light of the Company’s challenges and opportunities following Admission, while at the same time ensuring that no individual (or a small group of individuals) can dominate the Board’s decision making. The Company will appraise the structure of the Board on an ongoing basis.

The Board intends to meet regularly to review, formulate and approve the Enlarged Group’s strategy, budgets, and corporate actions and oversee the Enlarged Group’s progress towards its goals.

The Company has established an Audit Committee, a Remuneration Committee and a Nomination Committee, each with formally delegated duties and responsibilities and with written terms of reference. The Company will review its compliance with the recommendations of the QCA Code and, following Admission, report in its annual report and accounts and on its website where it complies and explain where it does not comply

Corporate Structure Chart

Research

Read the latest research reports on BSF Enterprise.

Company undergoes a 5-faceted growth-ready restructuring.
Shard Capital - BSF Enterprise Plc, Early Mover in UK Lab-grown Meat.

Advisors

Company Secretary

Geoffrey Robert Baker

Auditors to the Company

PKF Littlejohn LLP
5 Westferry Circus
London, E14 4HD
United Kingdom

Solicitors to the Company as to English Law

Reynolds Porter Chamberlain LLP
Tower Bridge House
St Katharine’s Way
London
E1W 1AA

Registrar

Share Registrars Limited
The Courtyard, 17 West Street
Farnham
Surrey GU9 7DR
United Kingdom

Reporting Accountants to the Company

Crowe U.K. LLP
55 Ludgate Hill
London EC4M 7JW
United Kingdom

Placing Agent and Advisor

Shard Capital Partners LLP
23rd Floor, 20 Fenchurch St,
London EC3M 3BY
United Kingdom

Communications

SEC Newgate (UK)
14 Greville Street
​London EC1N 8SB

Financial Calendar

Annual General Meeting (AGM)

15 March 2023

Annual Results

31 January 2023

Last updated 10/02/2023.